# Medications That Cause Hair Loss in Women: Full List

> Over 300 medications can trigger hair loss in women.

*More than 300 drugs are documented to cause hair loss in women, predominantly through telogen effluvium — premature entry of follicles into the resting phase. Major culprits include anticoagulants (heparin, warfarin, the newer oral anticoagulants), beta-blockers, ACE inhibitors, oral contraceptives, valproic acid, lithium, and isotretinoin. Chemotherapy agents cause anagen effluvium — direct destruction of actively growing follicles — with onset within 2–5 weeks.*

- Canonical: https://beautycomparison.com/medication-hair-loss-women
- Reviewed: 2026-06-20
- Publisher: Beauty Comparison (Beauty Comparison Editorial) — independent, brand-neutral

## Key takeaways
- Drug-induced hair loss most often presents as telogen effluvium — diffuse shedding 2–4 months after starting the offending medication — rather than a patterned or patchy loss.
- Major categories include anticoagulants (heparin, warfarin, rivaroxaban, apixaban), antihypertensives (beta-blockers, ACE inhibitors), anticonvulsants (valproic acid, carbamazepine), mood-stabilizers (lithium), and hormonal agents (oral contraceptives, androgens).
- Chemotherapy drugs cause anagen effluvium — direct follicle damage within 2–5 weeks — which is usually more severe and rapid than telogen effluvium.
- Valproic acid (sodium valproate) has one of the highest rates of drug-induced hair loss, affecting 12–28% of users; lithium affects 12–19%.
- Hair loss from medications is almost always reversible: shedding typically stops 3–6 months after discontinuation, with cosmetically visible regrowth in 12–18 months.
- Never stop a prescribed medication without consulting your doctor — for many conditions, the risks of discontinuation outweigh the hair loss side effect, and dose adjustment or a switch to an alternative drug may resolve the problem.

## Why Medications Cause Hair Loss

Hair loss triggered by a drug is called **drug-induced alopecia**. It is far more common than most patients and clinicians expect — more than 300 prescription and over-the-counter medications have been implicated. In women, who are already at greater risk of hormonally driven hair loss, a drug trigger can compound an underlying predisposition.

Two distinct mechanisms account for almost all cases:

### Telogen Effluvium (the most common mechanism)
The drug prematurely pushes growing (anagen) follicles into the resting (telogen) phase. After approximately 2–3 months — the normal duration of telogen — those follicles shed simultaneously, causing a diffuse increase in daily shedding rather than a bald patch. The hair is lost in its normal telogen (club) form with a white bulb at the root. Because of this delay, patients often cannot connect the hair loss to the medication that started it.

### Anagen Effluvium (predominantly chemotherapy)
The drug directly damages the rapidly dividing matrix cells of actively growing follicles, causing the hair shaft to taper, fracture, and break at the scalp surface. Onset is rapid — often within 2–5 weeks of exposure. Loss can be extensive and distressing but is nearly always reversible once treatment ends.

---

## The Full Category-by-Category List

### Anticoagulants (Blood Thinners)

All anticoagulant classes have been implicated in telogen effluvium, though the exact risk rate is poorly quantified because anticoagulant patients are often acutely unwell:

| Drug | Notes |
|---|---|
| Heparin (unfractionated and low-molecular-weight) | Among the most frequently reported; dose-dependent |
| Warfarin | Reported consistently across decades |
| Rivaroxaban (Xarelto) | Listed in prescribing information; risk appears similar to warfarin |
| Dabigatran (Pradaxa) | Reported in pharmacovigilance data |
| Apixaban (Eliquis) | Reported; likely class effect |

**Onset:** Typically 2–4 months after starting or increasing the dose.

---

### Antihypertensives

Beta-blockers and ACE inhibitors are the most frequently reported antihypertensive causes:

| Drug | Class |
|---|---|
| Propranolol, metoprolol, atenolol | Beta-blockers |
| Captopril, enalapril, lisinopril | ACE inhibitors |

Beta-blocker-induced hair loss may also have a direct follicular effect beyond simple telogen shift. Calcium channel blockers (amlodipine, diltiazem) are occasionally reported but less commonly.

---

### Hormonal Agents

This is particularly relevant to women. Hormonal therapies can cause hair loss during use, on initiation, or paradoxically on discontinuation:

| Drug/Class | Mechanism | Timing |
|---|---|---|
| Combined oral contraceptive pills (stopping) | Withdrawal of estrogen prolong anagen → telogen shift | 1–3 months after stopping |
| Progesterone-dominant pills / implants | Androgenic progestins trigger androgenetic pattern loss in susceptible women | During use |
| Levonorgestrel, norethindrone | High androgenic index; most likely to cause hair thinning | During use |
| Androgens / anabolic steroids | Direct androgen excess at the follicle | During use |
| Danazol | Androgenic; used in endometriosis | During use |
| HRT (hormone replacement therapy) | Less commonly implicated; see context for type and dose | Variable |

When evaluating pill-related hair loss, the androgenicity of the progestin component matters: desogestrel, norgestimate, and drospirenone have the lowest androgenic profiles, while levonorgestrel and norethindrone are the highest.

---

### Anticonvulsants

Valproic acid (sodium valproate / Depakote) has the highest documented incidence of hair loss of any anticonvulsant — affecting **12–28% of users** — and can cause both diffuse telogen effluvium and changes in hair texture (hair becomes wavier or curlier). The mechanism is thought to include effects on zinc metabolism and biotin cycling:

| Drug | Estimated hair loss rate |
|---|---|
| Valproic acid | 12–28% |
| Carbamazepine (Tegretol) | ~6% |
| Phenytoin (Dilantin) | Occasional reports |
| Lamotrigine | Less frequently reported |

---

### Mood Stabilizers and Psychiatric Medications

**Lithium** causes telogen effluvium in 12–19% of users, making it one of the most common drug causes of hair loss overall. Most antidepressants and antipsychotics carry lower but non-zero risk:

| Drug Class | Examples |
|---|---|
| Mood stabilizers | Lithium |
| Antidepressants (SSRIs) | Fluoxetine, sertraline, paroxetine — individual reports; low overall incidence |
| Antidepressants (others) | Bupropion, venlafaxine — case reports |
| Antipsychotics | Variable; clozapine and olanzapine occasionally reported |
| Anti-anxiety | Some benzodiazepines — rare case reports |

---

### Retinoids

Both oral and topical retinoids can cause hair loss, though oral isotretinoin (Accutane) used for acne is the most clinically significant. Oral retinoids accelerate telogen conversion, typically causing diffuse shedding 1–3 months into treatment. Topical retinoids ([tretinoin](/[retinol](/retinol)-vs-[tretinoin](/retinol-vs-tretinoin))) cause hair loss much less commonly.

---

### Antifungal Agents

Voriconazole (a systemic antifungal used for serious infections) is particularly documented; fluconazole has occasional case reports. Terbinafine (Lamisil), used for onychomycosis, carries a low risk.

---

### Cholesterol-Lowering Agents (Statins)

Statins are a widely discussed but actually low-incidence cause of hair loss. Post-marketing reports exist for atorvastatin and simvastatin, but the absolute risk is low, and causation is complicated by confounding (older age, underlying illness). If noticed, shedding is typically mild and often resolves without discontinuation.

---

### Chemotherapy Agents

Cytotoxic chemotherapy causes **anagen effluvium** — the most severe and rapid drug-induced hair loss. Nearly all hair may be lost within weeks of starting treatment. The good news: regrowth almost always begins within 3–6 months of completing treatment. Some patients notice a temporary change in hair texture or color after regrowth.

Drugs with the highest rates of complete alopecia include:
- Cyclophosphamide, doxorubicin, etoposide, paclitaxel, docetaxel

Scalp cooling (cooling caps) worn during infusion reduces blood flow to follicles, limiting drug exposure and reducing hair loss in selected chemotherapy regimens; discuss this option with your oncologist.

---

### Immunosuppressants and Biologic Agents

Newer biologic agents — including immune checkpoint inhibitors (nivolumab, pembrolizumab) and anti-CD20 therapies (rituximab) — can trigger inflammatory hair disorders with increased catagen/telogen follicles. Methotrexate and azathioprine can also cause hair loss; the latter through direct follicular toxicity.

---

### Other Medications to Know

| Drug | Use |
|---|---|
| Levodopa / bromocriptine | Parkinson's disease |
| Amphetamines | ADHD, narcolepsy |
| Interferons (alpha, beta, gamma) | Hepatitis C, MS |
| Allopurinol | Gout |
| NSAIDs (high-dose, chronic) | Pain / anti-inflammatory — rare, low-risk |
| Cimetidine | Acid suppression |
| Antithyroid drugs (propylthiouracil, methimazole) | Hyperthyroidism |

---

## Identifying Drug-Induced Hair Loss: The Key Steps

1. **Timeline:** Hair loss appearing approximately **2–4 months** after starting, increasing the dose of, or switching a medication is the strongest clue.
2. **Pattern:** Diffuse shedding across the scalp (not a defined bald patch) points toward telogen effluvium.
3. **Drug history:** List every medication — prescription, OTC, hormonal, herbal, or supplement — started in the three months before shedding began.
4. **Rule out other causes:** Iron deficiency, thyroid disease, and nutritional deficiencies can mimic drug-induced telogen effluvium and are often checked simultaneously with a blood panel (CBC, ferritin, TSH, vitamin D).

---

## Will My Hair Grow Back?

In the vast majority of drug-induced cases, **yes** — hair loss reverses once the offending medication is stopped:

- **Shedding reduces:** 3–6 months after discontinuation
- **Visible regrowth:** 3–6 months after shedding stops
- **Cosmetically significant recovery:** 12–18 months

The exception is long-term androgenetic alopecia triggered or unmasked by androgenic medications in genetically susceptible women — this may persist and require specific treatment even after stopping the drug.

---

## What to Do: Never Stop a Medication Without Medical Advice

The most important practical point: **do not stop a prescribed medication because you suspect it is causing hair loss without first speaking to the prescribing doctor or a dermatologist.** For most conditions — epilepsy, anticoagulation after a clot, lithium for bipolar disorder — the risks of abrupt discontinuation are serious, and options including dose adjustment or switching to an alternative drug with a lower hair-loss profile almost always exist.

If you believe a medication is causing hair loss, see a dermatologist to confirm the diagnosis, then work with your prescriber to review your options. The [hair loss dermatologist visit guide](/when-to-see-dermatologist-hair-loss) covers exactly what to expect from that appointment.

## FAQ
**What medications are most likely to cause hair loss in women?**

The highest-risk medications for drug-induced hair loss in women are valproic acid (12–28% incidence), lithium (12–19%), heparin, beta-blockers such as propranolol and metoprolol, ACE inhibitors, oral contraceptives with high-androgenicity progestins (levonorgestrel, norethindrone), and isotretinoin (oral retinoid). Chemotherapy drugs cause the most severe and rapid hair loss through a different mechanism (anagen effluvium rather than telogen effluvium).

**How long after starting a medication does drug-induced hair loss appear?**

Most drug-induced telogen effluvium appears 2–4 months after starting, increasing the dose of, or switching the offending medication. This lag corresponds to the normal telogen phase duration — follicles pushed prematurely into rest then shed on their usual 3-month cycle. Chemotherapy-related anagen effluvium is an exception, appearing within 2–5 weeks of starting treatment.

**Will hair loss stop if I stop the medication?**

In most cases, yes. Shedding typically slows and stops within 3–6 months of discontinuing the responsible drug, with visible regrowth following over the next 3–6 months. Cosmetically significant recovery usually takes 12–18 months total. The exception is if the medication unmasked underlying androgenetic alopecia in a genetically susceptible person — that component may persist and need separate treatment.

**Can birth control pills cause hair loss?**

Yes, in two ways. Stopping the pill triggers a temporary telogen effluvium 1–3 months after discontinuation as estrogen levels drop. Additionally, pills containing androgenic progestins (levonorgestrel, norethindrone, norgestrel) can provoke androgenetic-pattern thinning in women who are genetically susceptible. Pills with anti-androgenic or low-androgenicity progestins (drospirenone, desogestrel, norgestimate) carry a lower hair-loss risk and can even be used therapeutically for hormonally driven hair loss.

**Can I take anything to reduce hair loss while staying on the medication?**

Evidence for supplements that prevent drug-induced telogen effluvium is limited. Valproic acid-induced hair loss may respond to zinc supplementation (valproate may deplete zinc). Biotin supplementation is sometimes recommended but only corrects a biotin deficiency, which valproate may cause. Minoxidil (2% or 5% topical foam) can support regrowth while you remain on an unavoidable medication. Always discuss any additions with your doctor.

**Do statins cause hair loss?**

Statins appear in post-marketing reports as a possible cause of hair loss, but the absolute incidence is low and causation is difficult to establish given that older age and cardiovascular disease independently increase hair loss risk. If you notice hair thinning on a statin, mention it to your doctor — alternatives within the class or a non-statin lipid-lowering approach may be considered — but do not stop a prescribed statin without medical advice.

## Sources
- Alopecia from drugs — DermNet — DermNet NZ: https://dermnetnz.org/topics/alopecia-from-drugs
- Culprits of Medication-Induced Telogen Effluvium, Part 1 — PubMed / Cutis (2024-01-01): https://pubmed.ncbi.nlm.nih.gov/38290075/
- Culprits of Medication-Induced Telogen Effluvium, Part 2 — PubMed / Cutis (2024-03-01): https://pubmed.ncbi.nlm.nih.gov/38478950/
- Telogen Effluvium: A Review — PubMed Central / International Journal of Trichology: https://pmc.ncbi.nlm.nih.gov/articles/PMC4606321/
- Hair Loss in Women: Causes, Treatment & Prevention — Cleveland Clinic: https://my.clevelandclinic.org/health/diseases/16921-hair-loss-in-women
- Hair loss: Diagnosis and treatment — American Academy of Dermatology (aad.org): https://www.aad.org/public/diseases/hair-loss/treatment/diagnosis-treat

_Health information, not medical advice._